Diet-induced alterations in gut microflora contribute to lethal pulmonary damage in TLR2/TLR4-deficient mice

Cell Reports

Volumn 8, Issue 1, 2014, Pages 137-149

  Ji, Yewei ^a   Sun, Shengyi ^a   Goodrich, Julia K ^a   Kim, Hana ^a   Poole, Angela C ^a   Duhamel, Gerald E ^a   Ley, Ruth E ^a   Qi, Ling ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; METRONIDAZOLE; NEOMYCIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; VANCOMYCIN; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; CIPROFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL TRANSLOCATION; BACTERIAL TRANSMISSION; CAUSE OF DEATH; CELL DAMAGE; CONTROLLED STUDY; DISEASE SEVERITY; DYSBIOSIS; INNATE IMMUNITY; INTESTINE FLORA; LIPID DIET; LUNG INJURY; MALE; MORTALITY; MOUSE; MUCOSAL IMMUNITY; NONCARDIOGENIC LUNG EDEMA; NONHUMAN; PRIORITY JOURNAL; SPECIES COMPOSITION; TIGHT JUNCTION; WILD TYPE; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; COMPLICATION; DEFICIENCY; GENETICS; IMMUNOLOGY; INTESTINE; LUNG DISEASES; MICROBIOLOGY; MICROFLORA; PATHOLOGY; BLOOD VESSEL PERMEABILITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FEEDING BEHAVIOR; LUNG EDEMA; LUNG INFECTION; PHENOTYPE; PRINCIPAL COORDINATE ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); MUS;

ANIMALS; DIET, HIGH-FAT; DYSBIOSIS; IMMUNITY, INNATE; INTESTINES; LUNG DISEASES; MICE; MICE, INBRED C57BL; MICROBIOTA; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84904069723     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.05.040     Document Type: Article

References (62)

1. Abreu M.T., Fukata M., Arditi M. TLR signaling in the gut in health and disease. J.Immunol. 2005, 174:4453-4460.
2. Aronesty, E. (2011). ea-utils: command-line tools for processing biological sequencing data. http://code.google.com/p/ea-utils.
3. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., Cheng G., Yamasaki S., Saito T., Ohba Y., et al. Induction of colonic regulatory Tcells by indigenous Clostridium species. Science 2011, 331:337-341.
4. Bevins C.L., Salzman N.H. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat. Rev. Microbiol. 2011, 9:356-368.
5. Blainey P.C., Milla C.E., Cornfield D.N., Quake S.R. Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci. Transl. Med. 2012, 4:ra130.
6. Bourke W.J., O'Connor C.M., FitzGerald M.X., McDonnell T.J. Pseudomonas aeruginosa exotoxin A induces pulmonary endothelial cytotoxicity: protection by dibutyryl-cAMP. Eur. Respir. J. 1994, 7:1754-1758.
7. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
8. Caricilli A.M., Picardi P.K., de Abreu L.L., Ueno M., Prada P.O., Ropelle E.R., Hirabara S.M., Castoldi Â., Vieira P., Camara N.O., et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol. 2011, 9:e1001212.
9. Clarke S.F., Murphy E.F., Nilaweera K., Ross P.R., Shanahan F., O'Toole P.W., Cotter P.D. The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes 2012, 3:186-202.
10. Clemente J.C., Ursell L.K., Parfrey L.W., Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012, 148:1258-1270.
11. Couturier-Maillard A., Secher T., Rehman A., Normand S., De Arcangelis A., Haesler R., Huot L., Grandjean T., Bressenot A., Delanoye-Crespin A., et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J.Clin. Invest. 2013, 123:700-711.
12. Darveau R.P., Pham T.T., Lemley K., Reife R.A., Bainbridge B.W., Coats S.R., Howald W.N., Way S.S., Hajjar A.M. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect. Immun. 2004, 72:5041-5051.
13. Dasu M.R., Devaraj S., Park S., Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010, 33:861-868.
14. Dethlefsen L., Huse S., Sogin M.L., Relman D.A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008, 6:e280.
15. -/- mice. Nature 2012, 487:104-108.
16. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., Peaper D.R., Bertin J., Eisenbarth S.C., Gordon J.I., Flavell R.A. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
17. Erb-Downward J.R., Thompson D.L., Han M.K., Freeman C.M., McCloskey L., Schmidt L.A., Young V.B., Toews G.B., Curtis J.L., Sundaram B., et al. Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS ONE 2011, 6:e16384.
18. Fierer N., Jackson J.A., Vilgalys R., Jackson R.B. Assessment of soil microbial community structure by use of taxon-specific quantitative PCR assays. Appl. Environ. Microbiol. 2005, 71:4117-4120.
19. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 2007, 104:13780-13785.
20. Garrett W.S., Lord G.M., Punit S., Lugo-Villarino G., Mazmanian S.K., Ito S., Glickman J.N., Glimcher L.H. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007, 131:33-45.
21. Geny B., Khun H., Fitting C., Zarantonelli L., Mazuet C., Cayet N., Szatanik M., Prevost M.C., Cavaillon J.M., Huerre M., Popoff M.R. Clostridium sordellii lethal toxin kills mice by inducing a major increase in lung vascular permeability. Am. J. Pathol. 2007, 170:1003-1017.
22. Henao-Mejia J., Elinav E., Jin C., Hao L., Mehal W.Z., Strowig T., Thaiss C.A., Kau A.L., Eisenbarth S.C., Jurczak M.J., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185.
23. Hilty M., Burke C., Pedro H., Cardenas P., Bush A., Bossley C., Davies J., Ervine A., Poulter L., Pachter L., et al. Disordered microbial communities in asthmatic airways. PLoS ONE 2010, 5:e8578.
24. Hooper L.V., Littman D.R., Macpherson A.J. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
25. Jamieson A.M., Pasman L., Yu S., Gamradt P., Homer R.J., Decker T., Medzhitov R. Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science 2013, 340:1230-1234.
26. Ji Y., Sun S., Xia S., Yang L., Li X., Qi L. Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer Tcells and interleukin-4. J.Biol. Chem. 2012, 287:24378-24386.
27. Ji Y., Sun S., Xu A., Bhargava P., Yang L., Lam K.S., Gao B., Lee C.H., Kersten S., Qi L. Activation of natural killer Tcells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J.Biol. Chem. 2012, 287:13561-13571.
28. Jin C., Flavell R.A. Innate sensors of pathogen and stress: linking inflammation to obesity. J.Allergy Clin. Immunol. 2013, 132:287-294.
29. Kamada N., Chen G.Y., Inohara N., Núñez G. Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 2013, 14:685-690.
30. Koval M. Claudin heterogeneity and control of lung tight junctions. Annu. Rev. Physiol. 2013, 75:551-567.
31. Kumar H., Kawai T., Akira S. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 2009, 388:621-625.
32. Lammers A.J., de Porto A.P., de Boer O.J., Florquin S., van der Poll T. The role of TLR2 in the host response to pneumococcal pneumonia in absence of the spleen. BMC Infect. Dis. 2012, 12:139.
33. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
34. Lopetuso L.R., Scaldaferri F., Petito V., Gasbarrini A. Commensal Clostridia: leading players in the maintenance of gut homeostasis. Gut Pathog 2013, 5:23.
35. Lozupone C., Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 2005, 71:8228-8235.
36. McDonald D., Price M.N., Goodrich J., Nawrocki E.P., DeSantis T.Z., Probst A., Andersen G.L., Knight R., Hugenholtz P. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012, 6:610-618.
37. Momose Y., Maruyama A., Iwasaki T., Miyamoto Y., Itoh K. 16S rRNA gene sequence-based analysis of clostridia related to conversion of germfree mice to the normal state. J.Appl. Microbiol. 2009, 107:2088-2097.
38. Murray J.F. Pulmonary edema: pathophysiology and diagnosis. Int. J. Tuberc. Lung Dis. 2011, 15:155-160. i.
39. Perina D.G. Noncardiogenic pulmonary edema. Emerg. Med. Clin. North Am. 2003, 21:385-393.
40. Pusterla N., Jones M.E., Mohr F.C., Higgins J.K., Mapes S., Jang S.S., Samitz E.M., Byrne B.A. Fatal pulmonary hemorrhage associated with RTX toxin producing Actinobacillus equuli subspecies haemolyticus infection in an adult horse. J.Vet. Diagn. Invest. 2008, 20:118-121.
41. Saeed A.I., Rieder S.A., Price R.L., Barker J., Nagarkatti P., Nagarkatti M. Acute lung injury induced by Staphylococcal enterotoxin B: disruption of terminal vessels as a mechanism of induction of vascular leak. Microsc. Microanal. 2012, 18:445-452.
42. Salzman N.H., Hung K., Haribhai D., Chu H., Karlsson-Sjöberg J., Amir E., Teggatz P., Barman M., Hayward M., Eastwood D., et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 2010, 11:76-83.
43. Sha H., Yang L., Liu M., Xia S., Liu Y., Liu F., Kersten S., Qi L. Adipocyte spliced form of X-box-binding protein 1 promotes adiponectin multimerization and systemic glucose homeostasis. Diabetes 2014, 63:867-879.
44. Skerrett S.J., Wilson C.B., Liggitt H.D., Hajjar A.M. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L312-L322.
45. Slack E., Hapfelmeier S., Stecher B., Velykoredko Y., Stoel M., Lawson M.A., Geuking M.B., Beutler B., Tedder T.F., Hardt W.D., et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009, 325:617-620.
46. Sokol H., Seksik P., Furet J.P., Firmesse O., Nion-Larmurier I., Beaugerie L., Cosnes J., Corthier G., Marteau P., Doré J. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 2009, 15:1183-1189.
47. Songer J.G. Enteric Clostridia. Pathogenesis of Bacterial Infectionsin Animals 2004, 131-142. Blackwell, Oxford. C.L. Gyles, J.F. Prescott, J.G. Songer, C.O. Thoen (Eds.).
48. Sun S., Ji Y., Kersten S., Qi L. Mechanisms of inflammatory responses in obese adipose tissue. Annu. Rev. Nutr. 2012, 32:261-286.
49. Sun S., Xia S., Ji Y., Kersten S., Qi L. The ATP-P2X7 signaling axis is dispensable for obesity-associated inflammasome activation in adipose tissue. Diabetes 2012, 61:1471-1478.
50. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335-376.
51. Taur Y., Pamer E.G. The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr. Opin. Infect. Dis. 2013, 26:332-337.
52. Tilton S.C., Waters K.M., Karin N.J., Webb-Robertson B.J., Zangar R.C., Lee K.M., Bigelow D.J., Pounds J.G., Corley R.A. Diet-induced obesity reprograms the inflammatory response of the murine lung to inhaled endotoxin. Toxicol. Appl. Pharmacol. 2013, 267:137-148.
53. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
54. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., Sogin M.L., Jones W.J., Roe B.A., Affourtit J.P., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
55. Turnbaugh P.J., Ridaura V.K., Faith J.J., Rey F.E., Knight R., Gordon J.I. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 2009, 1:ra14.
56. Ubeda C., Lipuma L., Gobourne A., Viale A., Leiner I., Equinda M., Khanin R., Pamer E.G. Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J.Exp. Med. 2012, 209:1445-1456.
57. Vaishnava S., Behrendt C.L., Ismail A.S., Eckmann L., Hooper L.V. Paneth cells directly sense gut commensals and maintain homeostasisat the intestinal host-microbial interface. Proc. Natl. Acad. Sci. USA 2008, 105:20858-20863.
58. Vijay-Kumar M., Aitken J.D., Carvalho F.A., Cullender T.C., Mwangi S., Srinivasan S., Sitaraman S.V., Knight R., Ley R.E., Gewirtz A.T. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010, 328:228-231.
59. Wang Z., Klipfell E., Bennett B.J., Koeth R., Levison B.S., Dugar B., Feldstein A.E., Britt E.B., Fu X., Chung Y.M., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472:57-63.
60. Willing B.P., Russell S.L., Finlay B.B. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat. Rev. Microbiol. 2011, 9:233-243.
61. Yoshimoto S., Loo T.M., Atarashi K., Kanda H., Sato S., Oyadomari S., Iwakura Y., Oshima K., Morita H., Hattori M., et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013, 499:97-101.
62. Zenewicz L.A., Yin X., Wang G., Elinav E., Hao L., Zhao L., Flavell R.A. IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J.Immunol. 2013, 190:5306-5312.